Literature DB >> 2752884

Low testosterone levels in diabetic men and animals: a possible role in testicular impotence.

H Fushimi1, H Horie, T Inoue, M Kameyama, K Kanao, S Ishihara, T Tsujimura, H Nunotani, T Minami, Y Okazaki.   

Abstract

Poorly controlled NOD spontaneously diabetic mice were proven to have significantly less plasma and testicular testosterone than well-controlled diabetic mice (489 +/- 15 ng/dl and 3.89 +/- 0.79 micrograms/100 g tissue, vs. 176 +/- 24 and 9.00 +/- 1.24, respectively), and these in turn had significantly less than NOD non-diabetic control mice. These data were consistent with our previous observation of a decrease in total plasma and testicular testosterone levels in streptozotocin diabetic rats. A greater difference between total plasma testosterone levels and free testosterone levels was found in streptozotocin diabetic rats (17 +/- 4 ng/dl vs. 91 +/- 7 ng/dl) than in control rats (660 +/- 141 vs. 352 +/- 77). Fat droplets, depicting blocked testosterone synthesis, were found in the testicular Leydig cells of streptozotocin diabetic rats and disappeared with insulin treatment. No difference was found among plasma total testosterone concentrations in people in different stages of diabetes, as had been previously reported. However, human diabetic males, free of complications but poorly controlled, had less free testosterone than those without complications but well controlled (18.0 +/- 2.0 pg/ml vs. 22.8 +/- 1.3), who in turn had significantly less than age-matched controls (25.3 +/- 1.1 pg/ml). These data suggest gonadal dysfunction in diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2752884     DOI: 10.1016/0168-8227(89)90069-7

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

1.  Molecular targets for diabetes mellitus-associated erectile dysfunction.

Authors:  Elizabeth Yohannes; Jinsook Chang; Moses T Tar; Kelvin P Davies; Mark R Chance
Journal:  Mol Cell Proteomics       Date:  2009-12-10       Impact factor: 5.911

2.  Cancer risk in patients with diabetes mellitus.

Authors:  H O Adami; J McLaughlin; A Ekbom; C Berne; D Silverman; D Hacker; I Persson
Journal:  Cancer Causes Control       Date:  1991-09       Impact factor: 2.506

3.  Diabetes mellitus and risk of prostate cancer: a meta-analysis.

Authors:  S Bonovas; K Filioussi; A Tsantes
Journal:  Diabetologia       Date:  2004-05-26       Impact factor: 10.122

4.  Consecutive Low Doses of Streptozotocin Induce Polycystic Ovary Syndrome Features in Mice.

Authors:  Youngjae Ryu; Yong Jin Kim; Yoon Young Kim; Jungwoo Kim; Sung Woo Kim; Hoon Kim; Seung Yup Ku
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 5.923

5.  Correcting imbalance of sex hormones by a phosphodiesterase 5 inhibitor improves copulatory dysfunction in male rats with type 2 diabetes.

Authors:  Akiko Itoga; Xinmin Zha; Keiko Nagase; Yoshitaka Aoki; Hideaki Ito; Osamu Yokoyama
Journal:  BMJ Open Diabetes Res Care       Date:  2020-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.